Back to News
Market Impact: 0.3
$CAPR Stock Notification: Capricor Therapeutics has been Sued for Securities Fraud after Clinical Data Issues Disclosed – Investors are Alerted to Contact BFA Law by September 28
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Capricor Therapeutics faces a securities-fraud lawsuit following disclosed clinical-data issues, with investors urged to contact BFA Law by September 28. The litigation raises potential legal, regulatory, and investor-confidence risks for the biotechnology company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.65
Ticker Sentiment
CAPR-0.90
More News
- Street Calls of The Week
- Paraguay’s ousted president charged over banking scandal
- argenx reports positive phase 3 data for autoimmune myositis drug
- U.S. intelligence memo ties Nvidia’s Huang to alleged Chinese spy, FT reports
- Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup
- What Walker & Dunlop (WD) Said on Its Q3 Earnings Call